ALX ONCOLOGY HOLDINGS INC

ALXO

Form 3 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093894
Filing date: Mar 5, 2026
Earliest execution date:

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Filing's footnotes

1. The shares are held directly by the reporting person's spouse.

2. Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025.

3. One-third of the shares subject to the option vest on each of September 17, 2025, January 31, 2026 and June 30, 2026.

4. Shares subject to the option vest in 12 equal monthly installments beginning on February 26, 2026.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.